Video

Jeff Stark, MD: The Process of nr-ax-SpA Indexed to ICD-10

Jeff Stark, MD, discusses why nr-ax-SpA wasn't indexed and the process of having it included as an ICD-10 code.

With its recent addition to the ICD-10 coding manual, non-radiographic axial spondyloarthritis (nr-ax-SpA) can now be diagnosed more accurately by healthcare providers.

The coding manual only undergoes periodic updates that are widely spaced, Jeff Stark, MD, Head of US Immunology at UCB, said in a recent interview with HCPLive®. ICD-11 was already developed and released and in that manual, nr-ax-SpA is recognized there.

The implementation date of ICD-11 has not yet been set in the US, though.

To get a disease state indexed to an ICD code, the ICD-10 Coordination and Maintenance committee steps in. The committee meets twice a year to entertain potential changes to the diagnostic and procedural coding manual. Applications are received at committee meetings in March and September every year.

“I will say that the committee has a very high standard for what they will consider in terms of potential modifications to the coding manual, and those applications really have to meet a very high bar of clinical accuracy and unmet need to justify a modification of the manual,” Stark said in the interview.

The process may be lengthy, he added, but it is necessary to understand why the changes need to be made and the value that an update to the manual can bring.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.